BioNTech Says Moderna's New COVID Vax Infringes Its IP
BioNTech has launched a new patent infringement suit against Moderna, claiming that the rival's newer COVID-19 vaccine exploits BioNTech's "streamlined, domain-based" vaccine technology, according to a complaint filed in Delaware federal...To view the full article, register now.
Already a subscriber? Click here to view full article